Anti-thymocyte globulin plus etanercept as therapy for myelodysplastic syndromes (MDS): a phase II study.
Scott
Bart L
BL
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. bscott@fhcrc.org
Ramakrishnan
Aravind
A
Fosdal
Mark
M
Storer
Barry
B
Becker
Pamela
P
Petersdorf
Steve
S
Deeg
H Joachim
HJ